Literature DB >> 16451800

Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations.

Dedmer Schaafsma1, Annet B Zuidhof, S A Nelemans, Johan Zaagsma, Herman Meurs.   

Abstract

Currently, little is known about mechanisms underlying passive sensitization-induced nonspecific airway hyperresponsiveness. We sought to determine whether the nonspecific airway hyperresponsiveness observed after passive sensitization involves an increased role of Rho-kinase in airway smooth muscle contraction. In addition, the contribution of Rho-kinase to specific allergen-induced airway smooth muscle contraction was studied. Guinea pig tracheal smooth muscle preparations were incubated for 16 h, in the presence of serum obtained from nonsensitized guinea pigs or atopic serum obtained from actively ovalbumin-sensitized guinea pigs. After incubation, the contribution of Rho-kinase to histamine-, methacholine- or ovalbumin-induced isometric contractions was determined, using the specific Rho-kinase inhibitor Y-27632. Maximal contractions induced by histamine and methacholine were significantly increased in passively sensitized preparations, without a change in potency (-logEC50). In control preparations, Y-27632 reduced the potency of both agonists, without affecting maximal contraction. Remarkably, the increased agonist responsiveness induced by passive sensitization was fully normalized by Y-27632. Treatment with Y-27632 also reduced ovalbumin-induced contraction in these preparations. This study shows that the nonspecific airway smooth muscle hyperresponsiveness as well as the specific allergen responsiveness induced by passive sensitization are dependent on Rho-kinase. The complete inhibition by Y-27632 of the passive sensitization-induced increased responsiveness toward histamine and methacholine indicates a pivotal role of Rho-kinase in this process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16451800     DOI: 10.1016/j.ejphar.2005.12.043

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Caveolin-1 and force regulation in porcine airway smooth muscle.

Authors:  Venkatachalem Sathish; Binxia Yang; Lucas W Meuchel; Sarah K VanOosten; Alexander J Ryu; Michael A Thompson; Y S Prakash; Christina M Pabelick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-03-18       Impact factor: 5.464

Review 2.  Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models.

Authors:  Luigino Calzetta; Elena Pistocchini; Beatrice Ludovica Ritondo; Francesco Cavalli; Francesca Camardelli; Paola Rogliani
Journal:  Heliyon       Date:  2022-06-22

Review 3.  Airway smooth muscle in asthma: just a target for bronchodilation?

Authors:  Judith L Black; Reynold A Panettieri; Audreesh Banerjee; Patrick Berger
Journal:  Clin Chest Med       Date:  2012-07-11       Impact factor: 2.878

4.  Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab.

Authors:  Luigino Calzetta; Beatrice Ludovica Ritondo; Maria Gabriella Matera; Francesco Facciolo; Paola Rogliani
Journal:  Br J Pharmacol       Date:  2020-09-17       Impact factor: 8.739

5.  Mfge8 suppresses airway hyperresponsiveness in asthma by regulating smooth muscle contraction.

Authors:  Makoto Kudo; S M Amin Khalifeh Soltani; Stephen A Sakuma; William McKleroy; Ting-Hein Lee; Prescott G Woodruff; Jae Woo Lee; Katherine Huang; Chun Chen; Mehrdad Arjomandi; Xiaozhu Huang; Kamran Atabai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-26       Impact factor: 11.205

6.  Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo.

Authors:  Paola Rogliani; Maria Gabriella Matera; Francesco Facciolo; Clive Page; Mario Cazzola; Luigino Calzetta
Journal:  Br J Pharmacol       Date:  2020-01-29       Impact factor: 8.739

7.  Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction.

Authors:  Dedmer Schaafsma; I Sophie T Bos; Annet B Zuidhof; Johan Zaagsma; Herman Meurs
Journal:  Respir Res       Date:  2006-09-26

8.  Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways.

Authors:  Luigino Calzetta; Maria Gabriella Matera; Francesco Facciolo; Mario Cazzola; Paola Rogliani
Journal:  Respir Res       Date:  2018-04-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.